Stratec (ETR:SBS) Stock Price Down 2.4% – Should You Sell?

Stratec SE (ETR:SBS) shares were down 2.4% during mid-day trading on Monday . The company traded as low as €17.16 and last traded at €17.28. Approximately 5,163 shares changed hands during trading, a decline of 17% from the average daily volume of 6,253 shares. The stock had previously closed at €17.70.

Stratec Stock Performance

The company’s 50 day moving average price is €20.43 and its 200-day moving average price is €23.14. The stock has a market cap of $207.60 million, a P/E ratio of 20.73, a price-to-earnings-growth ratio of 10.43 and a beta of 0.72. The company has a debt-to-equity ratio of 55.08, a quick ratio of 1.65 and a current ratio of 4.19.

Stratec Company Profile

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.